Molecular Mechanisms of Cutaneous Immune-Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitors

Over the past few decades, immune checkpoint inhibitors (ICIs) have emerged as promising therapeutic options for the treatment of various cancers. These novel treatments effectively target key mediators of immune checkpoint pathways. Currently, ICIs primarily consist of monoclonal antibodies that sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Yi-Shan, Yu, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378098/
https://www.ncbi.nlm.nih.gov/pubmed/37504358
http://dx.doi.org/10.3390/curroncol30070498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378098/
https://www.ncbi.nlm.nih.gov/pubmed/37504358
http://dx.doi.org/10.3390/curroncol30070498

Ejemplares similares